Component: (Network and Table)
Network
00500 - Statement - Consolidated Statements of Cash Flows
(http://www.supernus.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Consolidated Statements of Cash FlowsPeriod [Axis]
2016-01-01 - 2016-12-31
2015-01-01 - 2015-12-31
2014-01-01 - 2014-12-31
Consolidated Statements of Cash Flows
 
 
 
Cash flows from operating activities
 
 
 
Net income (loss)
91,221,000  
13,944,000  
(10,925,000) 
Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities:
 
 
 
Loss on extinguishment of debt
671,000  
2,338,000  
2,592,000  
Change in fair value of derivative liability
(448,000) 
(193,000) 
(2,809,000) 
Unrealized loss on marketable securities
  
(154,000) 
Depreciation and amortization
2,399,000  
921,000  
928,000  
Amortization of deferred financing costs and debt discount
520,000  
748,000  
2,090,000  
Noncash interest expense on nonrecourse liability related to sale of future royalties
4,548,000  
3,541,000  
658,000  
Non-cash royalty revenue
(4,686,000) 
(3,038,000) 
(633,000) 
Share-based compensation expense
5,926,000  
4,090,000  
2,857,000  
Deferred income tax benefit
(41,787,000) 
  
Changes in operating assets and liabilities:
 
 
 
Accounts receivable
(15,619,000) 
(8,638,000) 
(12,216,000) 
Inventories
(4,214,000) 
854,000  
(6,289,000) 
Prepaid expenses and other assets
2,306,000  
(1,582,000) 
(1,144,000) 
Accounts payable
3,470,000  
2,061,000  
(2,054,000) 
Accrued sales deductions
15,149,000  
18,333,000  
7,461,000  
Accrued expenses
7,546,000  
507,000  
2,031,000  
Deferred product revenue, net
  
(7,882,000) 
Deferred licensing revenue
144,000  
149,000  
(204,000) 
Other non-current liabilities
(334,000) 
489,000  
1,198,000  
Net cash provided by (used in) operating activities
66,812,000  
 
34,524,000  
 
(24,495,000) 
 
Cash flows from investing activities
 
 
 
Purchases of marketable securities
(47,364,000) 
(63,859,000) 
(53,262,000) 
Sales and maturities of marketable securities
31,824,000  
37,581,000  
53,473,000  
Purchases of property and equipment
(1,603,000) 
(2,104,000) 
(593,000) 
Deferred legal fees
(18,821,000) 
(10,907,000) 
(2,277,000) 
Net cash used in investing activities
(35,964,000) 
 
(39,289,000) 
 
(2,659,000) 
 
Cash flows from financing activities
 
 
 
Proceeds from issuance of common stock
2,052,000  
1,867,000  
571,000  
Cash settlement of debt to equity conversion
  
(1,000) 
Proceeds from sale of future royalties
  
30,000,000  
Net cash provided by financing activities
2,052,000  
 
1,867,000  
 
30,570,000  
 
Net change in cash and cash equivalents
32,900,000  
 
(2,898,000) 
 
3,416,000  
 
Cash and cash equivalents at beginning of year
33,498,000  
36,396,000  
32,980,000  
Cash and cash equivalents at end of year
66,398,000  
 
33,498,000  
 
36,396,000  
 
Supplemental cash flow information:
 
 
 
Cash paid for interest
493,000  
825,000  
2,854,000  
Noncash financial activity:
 
 
 
Conversion of convertible notes and interest make-whole
4,162,000  
27,089,000  
14,887,000  
Exercise of warrants
 
652,000  
 
Deferred legal fees included in accounts payable and accrued expenses
5,122,000  
9,789,000  
2,228,000